Fierce Pharma | by Fraiser Kansteiner
Johnson & Johnson has kept global access at the heart of its Covid-19 vaccine supply efforts, pledging 500 million doses to lower-income countries late last year. Now, the drugmaker is setting aside another quarter-billion doses to shore up vaccination efforts in Africa.
Johnson & Johnson locked up a deal to provide the African Union with up to 400 million doses of its one-and-done Covid-19 vaccine through 2022, to be rolled out as it’s approved by the bloc’s 55 member states…
